Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto Culver grows U.K. skin-care portfolio

This article was originally published in The Tan Sheet

Executive Summary

Keeping with its strategy to grow the skin-care side of its business, the Melrose Park, Ill.-based firm acquires No. 2 U.K. skin-care brand Simple Health & Beauty Ltd. from private equity firm Duke Street. In the £240 million ($392 million) "substantially" cash deal announced Dec. 14, Alberto Culver gains Simple Health & Beauty's portfolio of more than 140 skin- and personal-care products. Morningstar analyst Lauren DeSanto wrote in a same-day note the price Alberto paid for Simple "is not outside the range for high-quality brands, particularly in skin care," adding with Alberto's strong U.K. hair-care presence "it's not surprising that the firm would look to build on this position into another category." Alberto Culver, which already markets St. Ives and Noxzema skin-care products, reported sales of $1.43 billion and profit of $119.4 million for its fiscal 2009

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel